Mirati Therapeutics Announces Departure of Chief Financial Officer Laurie Stelzer prnewswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from prnewswire.com Daily Mail and Mail on Sunday newspapers.
Mirati Therapeutics, Inc. (NASDAQ:MRTX – Get Free Report) has received a consensus rating of “Moderate Buy” from the thirteen research firms that are presently covering the stock, MarketBeat reports. One analyst has rated the stock with a sell recommendation, four have issued a hold recommendation and eight have assigned a buy recommendation to the company. […]
Mirati Therapeutics (NASDAQ:MRTX – Free Report) had its target price lifted by Oppenheimer from $56.00 to $62.00 in a research report released on Wednesday morning, MarketBeat reports. They currently have an outperform rating on the biotechnology company’s stock. MRTX has been the subject of a number of other reports. BMO Capital Markets decreased their price […]
Mirati Therapeutics (NASDAQ:MRTX – Free Report) had its price objective upped by Oppenheimer from $56.00 to $62.00 in a research note published on Wednesday, MarketBeat reports. They currently have an outperform rating on the biotechnology company’s stock. Other analysts have also issued research reports about the company. Scotiabank began coverage on Mirati Therapeutics in a […]
B Riley Weighs in on Mirati Therapeutics, Inc s Q3 2023 Earnings (NASDAQ:MRTX) wkrb13.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from wkrb13.com Daily Mail and Mail on Sunday newspapers.